More people should have an easier time accessing a crucial HIV-prevention medication under federal guidance issued Monday that clarifies that most private health plans must provide pre-exposure prophylaxis, or “PrEP,” without cost-sharing in order to help prevent new infections.
People who don’t have HIV take PrEP to reduce the chances of getting infected if they’re exposed to the virus. PrEP can stop the spread of HIV infection throughout the body.
On June 21, 2019 the U.S. Preventative Services Task Force recommended that clinicians offer PrEP with antiviral therapy to patients at high risk for HIV infection. The recommendation largely took ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.